Fungicidal amides

US9730447B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9730447-B2
Application numberUS-201414783622-A
CountryUS
Kind codeB2
Filing dateApr 11, 2014
Priority dateApr 15, 2013
Publication dateAug 15, 2017
Grant dateAug 15, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof, wherein A is a radical selected from the group consisting of A-1 through A-11, L is —C(R 12a )R 12b —C(R 13a )R 13b —; or 1,2-phenylene G is a radical selected from the group consisting of and R 1 , R 2 , R 12a , R 12b , R 13a , R 13b and Q are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound selected from Formula 1, N-oxides and salts thereof, wherein A is a radical selected from the group consisting of A-11 Z is O or S; R 1 is H, cyclopropyl or C 1 -C 2 alkoxy; L is —C(R 12a )R 12b —C(R 13a )R 13b —, wherein the carbon atom bonded to R 12a and R 12b is also bonded to the carboxamide nitrogen atom in Formula 1; or 1,2-phenylene optionally substituted with up to 4 substituents independently selected from halogen and C 1 -C 2 alkyl; G is a radical selected from the group consisting of each R 2 is independently halogen, nitro, cyano, C 1 -C 5 alkyl, C 1 -C 5 haloalkyl, C 1 -C 5 alkoxy, C 1 -C 5 haloalkoxy or C 3 -C 5 cycloalkyl; B 1 is CH or N; B 2 is CH or N; B 3 is CH or N; provided when B 1 and B 2 are both N, then B 3 is CH; R 3 is halogen, C 1 -C 3 alkyl or C 1 -C 3 haloalkyl; R 4 is halogen, C 1 -C 3 alkyl or C 1 -C 3 haloalkyl; R 5 is H, halogen, C 1 -C 3 alkyl or C 1 -C 3 haloalkyl; R 6 is C 1 -C 2 alkyl; R 7 is halogen, C 1 -C 3 alkyl or C 1 -C 3 haloalkyl; R 8 is H, C 1 -C 2 alkyl or C 1 -C 2 haloalkyl; R 9a is H, halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl or C 1 -C 3 alkylthio; R 9b is H, halogen, C 1 -C 3 alkyl or C 1 -C 3 haloalkyl; R 10 is halogen, C 1 -C 3 alkyl or C 1 -C 3 haloalkyl; R 11 is halogen, C 1 -C 3 alkyl or C 1 -C 3 haloalkyl; R 20 is halogen, C 1 -C 3 alkyl or C 1 -C 3 haloalkyl; R 21 is H, C 1 -C 2 alkyl or C 1 -C 2 haloalkyl; R 22 is H, halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl or C 1 -C 3 alkylthio; R 23 is H, halogen, C 1 -C 3 alkyl or C 1 -C 3 haloalkyl; R 24 is H, halogen, C 1 -C 3 alkyl or C 1 -C 3 haloalkyl; R 25 is H, C 1 -C 3 alkyl or C 1 -C 3 haloalkyl; m is 0, 1 or 2; n is 0, 1, 2 or 3; R 12a and R 12b are each independently H, C 1 -C 2 alkyl or C 1 -C 2 haloalkyl; or R 12a and R 12b are taken together as C 2 -C 5 alkanediyl; R 13a is H, halogen, C 1 -C 2 alkyl, C 1 -C 2 haloalkyl, C 1 -C 2 alkoxy, C 1 -C 2 haloalkoxy, C 1 -C 2 alkylthio or C 1 -C 2 alkoxyamino; R 13b is H, halogen, C 1 -C 2 alkyl or C 1 -C 2 haloalkyl; or R 13a and R 13b are taken together as C 2 -C 5 alkanediyl; Q is a 5-membered unsaturated or partially unsaturated heterocyclic ring containing ring members selected from carbon atoms and up to 4 heteroatoms independently selected from up to 1 O, up to 1 S and up to 4 N atoms, wherein up to 2 carbon atom ring members are independently selected from C(═O), the heterocyclic ring optionally substituted with one substituent on a ring member distal relative to the ring member connecting the heteroaromatic ring to the remainder of Formula 1, said optional substituent selected from R 14c on carbon atom ring members and from R 14n on nitrogen atom ring members, the heterocyclic ring further optionally substituted with substituents selected from R 15c on carbon atom ring members and R 15n on nitrogen atom ring members; each R 14c is independently halogen, cyano, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 2 -C 3 alkoxycarbonyl or C 2 -C 3 alkylcarbonyl; or a phenyl ring optionally substituted with up to 5 substituents independently selected from R 16 ; or a heteroaromatic ring optionally substituted with up to 4 substituents independently selected from R 17c on carbon atom ring members and from R 17n on nitrogen atom ring members; or two R 14c bonded to adjacent carbon atoms are taken together with carbon atom ring members to form a 5- or 6-membered carbocyclic or partially aromatic ring, the ring optionally substituted with halogen or C 1 -C 4 alkyl; each R 14n is independently C 1 -C 3 alkyl, C 1 -C 3 haloalkyl or C 1 -C 3 alkoxy; or a phenyl ring optionally substituted with up to 5 substituents independently selected from R 18 ; or a heteroaromatic ring optionally substituted with up to 4 substituents independently selected from R 19c on carbon atom ring members and from R 19n on nitrogen atom ring members; each R 15c is independently halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl or C 1 -C 3 alkoxy; each R 15n is independently C 1 -C 3 alkyl, C 1 -C 3 haloalkyl or C 1 -C 3 alkoxy; each R 16 , R 17c , R 18 and R 19c is independently halogen, cyano, C 1 -C 2 alkyl, C 1 -C 2 haloalkyl, C 1 -C 2 alkoxy or C 1 -C 2 haloalkoxy; and each R 17n and R 19n is independently C 1 -C 2 alkyl, C 1 -C 2 haloalkyl or C 1 -C 2 alkoxy. 2. A compound of claim 1 wherein Z is 0; L is —C(R 12a )R 12b —C(R 13a )R 13b —; or 1,2-phenylene optionally substituted with up to 2 substituents independently selected from F, Cl, Br and CH 3 ; G is selected from the group consisting of G-1, G-2, G-3 and G-4; each R 2 is independently halogen or C 1 -C 5 alkyl; n is 0, 1 or 2; R 3 is halogen, C 1 -C 2 alkyl or C 1 -C 2 haloalkyl; R 4 is halogen, C 1 -C 2 alkyl or C 1 -C 2 haloalkyl; R 5 is H, halogen, C 1 -C 2 alkyl or C 1 -C 2 haloalkyl; R 6 is CH 3 ; R 7 is halogen, C 1 -C 2 alkyl or C 1 -C 2 haloalkyl; R 8 is H or CH 3 ; R 9a is halogen, C 1 -C 2 alkyl, C 1 -C 2 haloalkyl or C 1 -C 2 alkylthio; R 9b is H, halogen, C 1 -C 2 alkyl; R 10 is halogen, C 1 -C 2 alkyl or C 1 -C 2 haloalkyl; R 11 is halogen, C 1 -C 2 alkyl or C 1 -C 2 haloalkyl; R 22 is F, Cl, CH 3 or CF 3 ; R 12a is H or CH 3 ; R 12b is H or CH 3 ; or R 12a and R 12b are taken as C 2 or C 3 alkanediyl; R 13a is H, CH 3 , or OCH 3 ; R 13b is H or CH 3 ; or R 13a and R 13b are taken together as C 2 or C 3 alkanediyl; Q is selected from wherein R 14 is bonded to a ring member distal relative to the ring member connecting the Q ring to the remainder of Formula 1, and independently selected from R 14c on carbon atom ring members and R 14n on nitrogen atom ring members; each R 15 is independently selected from R 15c on carbon atom ring members and R 15n on nitrogen atom ring members; each x is independently 0 or 1; each y is independently 0, 1 or 2; each z is independently 0, 1, 2 or 3; each R 16 , R 17c , R 18 and R 19c is independently F, Cl, Br, CH 3 , CHF 2 or CF 3 ; and each R 17n and R 19n is CH 3 . 3. The compound of claim 2 wherein A is selected from the group consisting of A-1, A-2, A-4 and A-8; L is —C(R 12a )R 12b —C(R 13a )R 13b —; G is selected from the group consisting of G-1 and G-4; B 1 is CH; each R 2 is independently F, Cl, Br or CH 3 ; n is 0 or 1; R 3 is F, Cl, Br, CH 3 , CHF 2 or CF 3 ; R 4 is F, Cl, Br, CH 3 , CHF 2 or CF 3 ; R 5 is H, halogen, CH 3 or C 1 haloalkyl; R 6 is CH 3 ; R 9a is F, Cl, Br, CHF 2 or CF 3 ; R 9b is H, halogen or C 1 -C 2 alkyl; R 20 is Cl, CH 3 or CF 3 ; R 21 is H or CH 3 ; R 14c is independently F, Cl, Br, CH 3 , CHF 2 or CF 3 ; Q is selected from each R 14n is CH 3 ; each R 15c is independently F, Cl, Br, CH 3 , CHF 2 or CF 3 ; and each R 15n is CH 3 . 4. The compound of claim 3 wherein A is selected from the group consisting of

Assignees

Inventors

Classifications

  • linked by a carbon chain containing aromatic rings · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9730447B2 cover?
Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof, wherein A is a radical selected from the group consisting of A-1 through A-11, L is —C(R 12a )R 12b —C(R 13a )R 13b —; or 1,2-phenylene G is a radical selected from the group consisting of and R 1 , R 2 , R 12a , R 12b , R 13a …
Who is the assignee on this patent?
Du Pont
What technology area does this patent fall under?
Primary CPC classification C07D215/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).